A Cost-Effectiveness Analysis of a First-in-Class, Triple Fixed Dose Combination Therapy Against Laba/Lama Therapy in Moderate-Severe COPD
May 1, 2018, 00:00
10.1016/j.jval.2018.04.1596
https://www.valueinhealthjournal.com/article/S1098-3015(18)31902-8/fulltext
Title :
A Cost-Effectiveness Analysis of a First-in-Class, Triple Fixed Dose Combination Therapy Against Laba/Lama Therapy in Moderate-Severe COPD
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31902-8&doi=10.1016/j.jval.2018.04.1596
First page :
Section Title :
Open access? :
No
Section Order :
822